Emmanuelle Meugnier

Emmanuelle Meugnier

Auto-generated profile, based on publicly available information

Emmanuelle Meugnier

Laboratoire CarMeN, INSERM U1060, INRAE U1397, https://dx.doi.org/27098Université Lyon 1, 69495 Pierre-Bénite, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
BCBlandine Chazarin
Blandine Chazarin
AZAnna Ziemianin
Anna Ziemianin
AEAlina L. Evans
Alina L. Evans
EMEmmanuelle Meugnier
Emmanuelle Meugnier
ELEmmanuelle Loizon
Emmanuelle Loizon
FBFabrice Bertile
Fabrice Bertile
Oxidative stress, which is believed to promote muscle atrophy, has been reported to occur in a few hibernators. However, hibernating bears exhibit efficient energy savings and muscle protein sparing, despite long-term physical inactivity and fasting. We hypothesized that the regulation of the oxidant/antioxidant balance and oxidative stress could favor skeletal muscle maintenance in hibernating brown bears. We showed that increased expressions of cold-inducible proteins CIRBP and RBM3 could favor muscle mass maintenance and alleviate oxidative stress during hibernation. Downregulation of the subunits of the mitochondrial electron transfer chain complexes I, II, and III, and antioxidant enzymes, possibly due to the reduced mitochondrial content, indicated a possible reduction of the production of reactive oxygen species in the hibernating muscle. Concomitantly, the upregulation of cytosolic antioxidant systems, under the control of the transcription factor NRF2, and the maintenance of the GSH/GSSG ratio suggested that bear skeletal muscle is not under a significant oxidative insult during hibernation. Accordingly, lower levels of oxidative damage were recorded in hibernating bear skeletal muscles. These results identify mechanisms by which limited oxidative stress may underlie the resistance to skeletal muscle atrophy in hibernating brown bears. They may constitute therapeutic targets for the treatment of human muscle atrophy.

24 May 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
LMLe Barz Mélanie
Le Barz Mélanie
CVCécile Vors
Cécile Vors
ECEmmanuel Combe
Emmanuel Combe
LJLaurie Joumard-Cubizolles
Laurie Joumard-Cubizolles
MLManon Lecomte
Manon Lecomte
MMMarie-Caroline Michalski
Marie-Caroline Michalski
BACKGROUND: High circulating levels of ceramides (Cer) and sphingomyelins (SM) are associated with cardiometabolic diseases. The consumption of whole fat dairy products, naturally containing such polar lipids (PL), is associated with health benefits, but the impact on sphingolipidome remains unknown. METHODS: In a 4-week randomized controlled trial, 58 postmenopausal women daily consumed milk PL-enriched cream cheese (0, 3, or 5 g of milk PL). Postprandial metabolic explorations were performed before and after supplementation. Analyses included SM and Cer species in serum, chylomicrons, and feces. The ileal contents of 4 ileostomy patients were also explored after acute milk PL intake. RESULTS: Milk PL decreased serum atherogenic C24:1 Cer, C16:1 SM, and C18:1 SM species ( P group < 0.05). Changes in serum C16+18 SM species were positively correlated with the reduction of cholesterol ( r = 0.706), LDL-C ( r = 0.666), and ApoB ( r = 0.705) ( P < 0.001). Milk PL decreased chylomicron content in total SM and C24:1 Cer ( P group < 0.001), parallel to a marked increase in total Cer in feces ( P group < 0.001). Milk PL modulated some specific SM and Cer species in both ileal efflux and feces, suggesting differential absorption and metabolization processes in the gut. CONCLUSION: Milk PL supplementation decreased atherogenic SM and Cer species associated with the improvement of cardiovascular risk markers. Our findings bring insights on sphingolipid metabolism in the gut, especially Cer, as signaling molecules potentially participating in the beneficial effects of milk PL. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02099032, NCT02146339. FUNDING: ANR-11-ALID-007-01; PHRCI-2014: VALOBAB, no. 14-007; CNIEL; GLN 2018-11-07; HCL (sponsor).

13 October 2017 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
RLRaquel Ataide Lima
Raquel Ataide Lima
RNRayner Anderson Ferreira Do Nascimento
Rayner Anderson Ferreira Do Nascimento
Rafaella Cristhine Pordeus LunaRafaella Cristhine Pordeus Luna
Rafaella Cristhine Pordeus Luna
DPDARLENE CAMATI PERSUHN
DARLENE CAMATI PERSUHN
Alexandre SilvaAlexandre Silva
Alexandre Silva
MCMaria José de Carvalho Costa
Maria José de Carvalho Costa
Studies of genes that play an important role in the development of obesity are needed, especially studies focusing on genes that regulate food intake and affect nutrient metabolism. For example, the beta-3 adrenergic receptor (ADRB3) responds to noradrenaline and mediates lipolysis in adipocytes. This was a controlled intervention study involving 40 overweight and obese adult women in which food intake, anthropometric measurements, biochemical analyses, and methylation levels of the ADRB3 gene were evaluated before and after intervention. The individuals were randomized into four groups: group 1 (G1) received 300 g of vegetables and legumes containing on average 191 μg/day of folate and 1 hazelnut oil capsule; group 2 (G2) received 300 g of vegetables and legumes containing on average 191 μg/day of folate and 1 placebo capsule; group 3 (G3) received 300 g of vegetables and legumes containing on average 90 μg/day of folate and 1 hazelnut oil capsule; and individuals in group 4 (G4) were only followed-up and maintained their regular dietary habits. Statistical analysis was performed using analysis of variance (ANOVA), Student’s t test and simple regression, using STATA 13 software. In the total sample, after the intervention, the women classified as overweight and obese did not present weight loss, and there was a reduction in the methylation levels of the ADRB3 gene and malondialdehyde, as well as an increase in high-density lipoprotein cholesterol and total antioxidant capacity. The beneficial effect of the intake of a hazelnut capsule on the methylation levels of the ADRB3 gene was demonstrated for the first time. ClinicalTrials.gov , NCT 02846025

23 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
LCLaura Cussonneau
Laura Cussonneau
CBChristian Boyer
Christian Boyer
CBCharlotte Brun
Charlotte Brun
CDChristiane Deval
Christiane Deval
ELEmmanuelle Loizon
Emmanuelle Loizon
LCLydie Combaret
Lydie Combaret
Muscle atrophy arises from a multiplicity of physio-pathological situations and has very detrimental consequences for the whole body. Although knowledge of muscle atrophy mechanisms keeps growing, there is still no proven treatment to date. This study aimed at identifying new drivers for muscle atrophy resistance. We selected an innovative approach that compares muscle transcriptome between an original model of natural resistance to muscle atrophy, the hibernating brown bear, and a classical model of induced atrophy, the unloaded mouse. Using RNA sequencing, we identified 4415 differentially expressed genes, including 1746 up- and 2369 down-regulated genes, in bear muscles between the active versus hibernating period. We focused on the Transforming Growth Factor (TGF)-β and the Bone Morphogenetic Protein (BMP) pathways, respectively, involved in muscle mass loss and maintenance. TGF-β- and BMP-related genes were overall down- and up-regulated in the non-atrophied muscles of the hibernating bear, respectively, and the opposite occurred for the atrophied muscles of the unloaded mouse. This was further substantiated at the protein level. Our data suggest TGF-β/BMP balance is crucial for muscle mass maintenance during long-term physical inactivity in the hibernating bear. Thus, concurrent activation of the BMP pathway may potentiate TGF-β inhibiting therapies already targeted to prevent muscle atrophy.

12 September 2016 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
KSKevin Seyssel
Kevin Seyssel
EMEmmanuelle Meugnier
Emmanuelle Meugnier
KLKim-Anne Lê
Kim-Anne Lê
CDChristine Durand
Christine Durand
EDEmmanuel Disse
Emmanuel Disse
MLMartine Laville
Martine Laville

22 September 2025 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
RHRhyma Hakkar
Rhyma Hakkar
CBCaroline E. Brun
Caroline E. Brun
Pascal LeblancPascal Leblanc
Pascal Leblanc
EMEmmanuelle Meugnier
Emmanuelle Meugnier
EBEmmanuelle BERGER
Emmanuelle BERGER
SRSOPHIE ROME
SOPHIE ROME
Extracellular vesicles (EVs) represent a cytokine‐independent pathway though which skeletal muscle (SkM) cells influence the fate of neighbouring cells, thereby regulating SkM metabolic homeostasis and regeneration. Although SkM‐EVs are increasingly being explored as a therapeutic strategy to enhance muscle regeneration or to induce the myogenic differentiation of induced pluripotent stem cells (iPSCs), the mechanisms governing their release from muscle cells remain poorly described. Moreover, because muscle regeneration involves a tightly regulated inflammatory response it also important to determine how inflammation alters SkM‐EV cargo and function in order to design more effective EV‐based therapies. To address this knowledge gap, we isolated and characterized the large and small EVs (lEVs, sEVs) released from SkM cells under basal conditions and in response to TNF‐α, a well‐established inflammatory mediator elevated in both acute muscle injury and chronic inflammatory conditions such as type 2 diabetes. We then evaluated the regenerative roles of these EV subtypes in vivo using a mouse model of cardiotoxin‐induced muscle injury, with a specific focus on their bioactive sphingolipid content. Using transmission, scanning or cryo‐electron microscopy, lipidomic profiling and an adenoviral construct to express labelled CD63 in myotubes, we demonstrated that SkM cells release both sEVs and lEVs primarily from the plasma membrane. Notably, sEVs were generated from specialized membrane folds enriched in the EV markers ALIX (ALG‐2 interacting protein X) and TSG101, as well as lipid raft‐associated lipids. During regeneration, sEVs promoted M1 macrophage polarization and migration and muscle stem cell (MuSC) differentiation, thereby accelerating muscle repair. In contrast, lEVs inhibited and promoted MuSC proliferation and impaired the transition from the pro‐inflammatory to the anti‐inflammatory response, an essential step for promoting MuSC differentiation. Treatment of isolated muscle fibres with SkM‐EVs revealed that the distinct effects of sEVs and lEVs on MuSC behaviour and macrophage phenotype could be largely explained by differences in their lipid composition, particularly the ratio of sphingosine‐1‐phosphate (S1P) subspecies. However, TNF‐α exposure altered these ratios in sEVs and impaired their regenerative functions on MuSC and their effect on macrophage migration and polarization. These results demonstrate for the first time the importance of the sphingolipid content of EVs released by skeletal muscle in their regenerative function within muscle tissue, largely explained by their role as carriers of different subspecies of sphingosine‐1‐phosphate. This suggests that modulating the sphingolipid composition of EVs could be a viable strategy to enhance the regenerative potential of muscle tissue in addition to therapeutic interventions.